|
1
|
Diastolic dysfunction: can it be diagnosed by Doppler echocardiography?
|
J Am Coll Cardiol
|
2004
|
3.89
|
|
2
|
Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure.
|
Circulation
|
2003
|
2.57
|
|
3
|
Use of rapamycin slows progression of cardiac transplantation vasculopathy.
|
Circulation
|
2003
|
2.46
|
|
4
|
Ventricular structure and function in hypertensive participants with heart failure and a normal ejection fraction: the Cardiovascular Health Study.
|
J Am Coll Cardiol
|
2007
|
2.30
|
|
5
|
Nonexcitatory, cardiac contractility modulation electrical impulses: feasibility study for advanced heart failure in patients with normal QRS duration.
|
Heart Rhythm
|
2006
|
2.13
|
|
6
|
Left heart failure with a normal ejection fraction: identification of different pathophysiologic mechanisms.
|
J Card Fail
|
2005
|
2.11
|
|
7
|
Baseline left ventricular volume and shape as determinants of reverse remodeling induced by surgical ventricular reconstruction.
|
Ann Thorac Surg
|
2011
|
2.07
|
|
8
|
Development of heart failure in chronic hypertensive Dahl rats: focus on heart failure with preserved ejection fraction.
|
Hypertension
|
2006
|
1.87
|
|
9
|
Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure.
|
Eur Heart J
|
2008
|
1.83
|
|
10
|
Impact of surgical ventricular reconstruction on stroke volume in patients with ischemic cardiomyopathy.
|
J Thorac Cardiovasc Surg
|
2010
|
1.79
|
|
11
|
PKA phosphorylation activates the calcium release channel (ryanodine receptor) in skeletal muscle: defective regulation in heart failure.
|
J Cell Biol
|
2003
|
1.78
|
|
12
|
Protein kinase A phosphorylation of the cardiac calcium release channel (ryanodine receptor) in normal and failing hearts. Role of phosphatases and response to isoproterenol.
|
J Biol Chem
|
2002
|
1.73
|
|
13
|
Multicenter evaluation of noninvasive cardiac output measurement by bioreactance technique.
|
J Clin Monit Comput
|
2008
|
1.68
|
|
14
|
The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure.
|
J Am Coll Cardiol
|
2007
|
1.63
|
|
15
|
Evaluation of a noninvasive continuous cardiac output monitoring system based on thoracic bioreactance.
|
Am J Physiol Heart Circ Physiol
|
2007
|
1.61
|
|
16
|
Proof of concept: hemodynamic response to long-term partial ventricular support with the synergy pocket micro-pump.
|
J Am Coll Cardiol
|
2009
|
1.57
|
|
17
|
Mechanisms of heart failure with well preserved ejection fraction in dogs following limited coronary microembolization.
|
Cardiovasc Res
|
2004
|
1.53
|
|
18
|
Chronic electrical stimulation during the absolute refractory period of the myocardium improves severe heart failure.
|
Eur Heart J
|
2004
|
1.52
|
|
19
|
Single-beat estimation of end-diastolic pressure-volume relationship: a novel method with potential for noninvasive application.
|
Am J Physiol Heart Circ Physiol
|
2006
|
1.50
|
|
20
|
The ventilatory anaerobic threshold in heart failure: a multicenter evaluation of reliability.
|
J Card Fail
|
2009
|
1.50
|
|
21
|
Outcomes following percutaneous coronary intervention in patients previously considered "without option": a subgroup analysis of the PACIFIC Trial.
|
J Interv Cardiol
|
2004
|
1.41
|
|
22
|
Temporary assist device for postcardiotomy cardiac failure.
|
Ann Thorac Surg
|
2004
|
1.40
|
|
23
|
Safety and feasibility of percutaneous delivery of a novel circulatory assist device (CircuLite® SYNERGY®) in the swine model.
|
EuroIntervention
|
2013
|
1.39
|
|
24
|
Heart failure with a normal ejection fraction: is it really a disorder of diastolic function?
|
Circulation
|
2003
|
1.32
|
|
25
|
Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling process.
|
Prog Biophys Mol Biol
|
2008
|
1.30
|
|
26
|
Myocardial recovery and the failing heart: myth, magic, or molecular target?
|
J Am Coll Cardiol
|
2012
|
1.17
|
|
27
|
Left ventricular form and function: scientific priorities and strategic planning for development of new views of disease.
|
Circulation
|
2004
|
1.16
|
|
28
|
Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness.
|
Circulation
|
2005
|
1.14
|
|
29
|
Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties.
|
J Am Coll Cardiol
|
2005
|
1.13
|
|
30
|
Clinical benefits of partial circulatory support in New York Heart Association Class IIIB and Early Class IV patients.
|
Eur J Cardiothorac Surg
|
2010
|
1.12
|
|
31
|
Development and validation of a patient questionnaire to determine New York Heart Association classification.
|
J Card Fail
|
2004
|
1.10
|
|
32
|
Role of impaired myocardial relaxation in the production of elevated left ventricular filling pressure.
|
Am J Physiol Heart Circ Physiol
|
2004
|
1.09
|
|
33
|
Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure.
|
J Am Coll Cardiol
|
2007
|
1.05
|
|
34
|
Cardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failure.
|
J Am Coll Cardiol
|
2008
|
1.03
|
|
35
|
Heart failure with normal ejection fraction: consideration of mechanisms other than diastolic dysfunction.
|
Curr Heart Fail Rep
|
2009
|
1.03
|
|
36
|
End-tidal CO2 pressure and cardiac performance during exercise in heart failure.
|
Med Sci Sports Exerc
|
2009
|
1.01
|
|
37
|
A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure.
|
Am Heart J
|
2011
|
1.01
|
|
38
|
The impact of left ventricular assist device-induced left ventricular unloading on the myocardial renin-angiotensin-aldosterone system: therapeutic consequences?
|
Eur Heart J
|
2009
|
1.00
|
|
39
|
Sarcomeric genes involved in reverse remodeling of the heart during left ventricular assist device support.
|
J Heart Lung Transplant
|
2005
|
0.98
|
|
40
|
Cardiac contractility modulation by non-excitatory currents: studies in isolated cardiac muscle.
|
Eur J Heart Fail
|
2005
|
0.98
|
|
41
|
Comparison of ventricular structure and function in Chinese patients with heart failure and ejection fractions >55% versus 40% to 55% versus <40%.
|
Am J Cardiol
|
2009
|
0.97
|
|
42
|
Cardiac output and cardiopulmonary responses to exercise in heart failure: application of a new bio-reactance device.
|
J Card Fail
|
2007
|
0.97
|
|
43
|
A computational method of prediction of the end-diastolic pressure-volume relationship by single beat.
|
Nat Protoc
|
2007
|
0.96
|
|
44
|
Disease-specific remodeling of cardiac mitochondria after a left ventricular assist device.
|
Ann Thorac Surg
|
2002
|
0.96
|
|
45
|
A multicenter study of noninvasive cardiac output by bioreactance during symptom-limited exercise.
|
J Card Fail
|
2009
|
0.94
|
|
46
|
First human use of partial left ventricular heart support with the Circulite synergy micro-pump as a bridge to cardiac transplantation.
|
Eur Heart J
|
2008
|
0.94
|
|
47
|
Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock.
|
Cochrane Database Syst Rev
|
2011
|
0.94
|
|
48
|
Autologous skeletal myoblast transplantation improved hemodynamics and left ventricular function in chronic heart failure dogs.
|
J Heart Lung Transplant
|
2005
|
0.94
|
|
49
|
Mechanisms underlying improvements in ejection fraction with carvedilol in heart failure.
|
Circ Heart Fail
|
2009
|
0.94
|
|
50
|
Subgroup analysis of a randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure.
|
J Card Fail
|
2011
|
0.93
|
|
51
|
Mortality in heart failure with preserved ejection fraction: an unacceptably high rate.
|
Eur Heart J
|
2011
|
0.93
|
|
52
|
Electric currents applied during refractory period enhance contractility and systolic calcium in the ferret heart.
|
Am J Physiol Heart Circ Physiol
|
2002
|
0.93
|
|
53
|
Impact of cardiac contractility modulation on left ventricular global and regional function and remodeling.
|
JACC Cardiovasc Imaging
|
2009
|
0.93
|
|
54
|
A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: rationale, design, and baseline patient characteristics.
|
Am Heart J
|
2008
|
0.92
|
|
55
|
Mechanical device-based methods of managing and treating heart failure.
|
Circulation
|
2005
|
0.91
|
|
56
|
Hemodynamic effects of partial ventricular support in chronic heart failure: results of simulation validated with in vivo data.
|
J Thorac Cardiovasc Surg
|
2007
|
0.90
|
|
57
|
Cardiac contractility modulation by electric currents applied during the refractory period.
|
Am J Physiol Heart Circ Physiol
|
2002
|
0.90
|
|
58
|
Surgical ventricular remodeling: a balancing act on systolic and diastolic properties.
|
J Thorac Cardiovasc Surg
|
2006
|
0.89
|
|
59
|
Nonexcitatory electrical signals for enhancing ventricular contractility: rationale and initial investigations of an experimental treatment for heart failure.
|
Am J Physiol Heart Circ Physiol
|
2005
|
0.88
|
|
60
|
Electrical signals applied during the absolute refractory period: an investigational treatment for advanced heart failure in patients with normal QRS duration.
|
J Am Coll Cardiol
|
2005
|
0.88
|
|
61
|
Load dependence of ventricular performance explained by model of calcium-myofilament interactions.
|
Am J Physiol Heart Circ Physiol
|
2002
|
0.87
|
|
62
|
Cardiac contractility modulation by electric currents applied during the refractory period in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
|
Am J Cardiol
|
2002
|
0.87
|
|
63
|
Biventricular assist device-induced right ventricular reverse structural and functional remodeling.
|
J Heart Lung Transplant
|
2005
|
0.86
|
|
64
|
Peak cardiac power measured noninvasively with a bioreactance technique is a predictor of adverse outcomes in patients with advanced heart failure.
|
Congest Heart Fail
|
2010
|
0.86
|
|
65
|
Partial left ventricular support implanted through minimal access surgery as a bridge to cardiac transplant.
|
J Thorac Cardiovasc Surg
|
2008
|
0.85
|
|
66
|
Bradycardic therapy improves left ventricular function and remodeling in dogs with coronary embolization-induced chronic heart failure.
|
J Pharmacol Exp Ther
|
2007
|
0.85
|
|
67
|
Continuous-flow left ventricular assist devices induce left ventricular reverse remodeling.
|
J Heart Lung Transplant
|
2013
|
0.85
|
|
68
|
Single-beat estimation of the left ventricular end-diastolic pressure-volume relationship in patients with heart failure.
|
Heart
|
2009
|
0.85
|
|
69
|
A polymerized bovine hemoglobin oxygen carrier preserves regional myocardial function and reduces infarct size after acute myocardial ischemia.
|
Am J Physiol Heart Circ Physiol
|
2006
|
0.84
|
|
70
|
The impact of extra cardiac comorbidities on pressure volume relations in heart failure and preserved ejection fraction.
|
J Card Fail
|
2011
|
0.83
|
|
71
|
Myoblast transfer in ischemic heart failure: effects on rhythm stability.
|
Cell Transplant
|
2009
|
0.83
|
|
72
|
Elective bridging to recovery after repair: the surgical approach to ventricular reverse remodeling.
|
Artif Organs
|
2008
|
0.82
|
|
73
|
Myocardial expression levels of micro-ribonucleic acids in patients with left ventricular assist devices signature of myocardial recovery, signature of reverse remodeling, or signature with no name?
|
J Am Coll Cardiol
|
2011
|
0.82
|
|
74
|
Hemodynamic changes as a diagnostic tool in acute heart failure--a pilot study.
|
Am J Emerg Med
|
2010
|
0.82
|
|
75
|
Ventricular pump function in heart failure with normal ejection fraction: insights from pressure-volume measurements.
|
Prog Cardiovasc Dis
|
2006
|
0.81
|
|
76
|
Clinical effects of cardiac contractility modulation (CCM) as a treatment for chronic heart failure.
|
Eur J Heart Fail
|
2012
|
0.81
|
|
77
|
Noninvasive measurement of cardiac performance in recovery from exercise in heart failure patients.
|
Clinics (Sao Paulo)
|
2011
|
0.81
|
|
78
|
In vitro ablation of cardiac valves using high-intensity focused ultrasound.
|
Ultrasound Med Biol
|
2005
|
0.80
|
|
79
|
The conundrum of functional mitral regurgitation in chronic heart failure.
|
J Am Coll Cardiol
|
2008
|
0.80
|
|
80
|
Right ventricular assist device in end-stage pulmonary arterial hypertension: insights from a computational model of the cardiovascular system.
|
Prog Cardiovasc Dis
|
2012
|
0.79
|
|
81
|
Two axial-flow Synergy Micro-Pumps as a biventricular assist device in an ovine animal model.
|
J Heart Lung Transplant
|
2012
|
0.79
|
|
82
|
Chasing the elusive pressure-volume relationships.
|
JACC Cardiovasc Imaging
|
2009
|
0.79
|
|
83
|
Feasibility study of a temporary percutaneous left ventricular assist device in cardiac surgery.
|
Ann Thorac Surg
|
2007
|
0.78
|
|
84
|
Cardiomyopathic etiology and SERCA2a reverse remodeling during mechanical support of the failing human heart.
|
Anesth Analg
|
2006
|
0.78
|
|
85
|
Do transmyocardial and percutaneous laser revascularization induce silent ischemia? An assessment by exercise testing.
|
Am Heart J
|
2002
|
0.77
|
|
86
|
Diastolic heart failure.
|
N Engl J Med
|
2004
|
0.76
|
|
87
|
Systolic heart failure and cardiac resynchronization therapy: a focus on diastole.
|
Int J Cardiovasc Imaging
|
2014
|
0.76
|
|
88
|
Evolution of renal function after partial and full mechanical support for chronic heart failure.
|
Int J Artif Organs
|
2014
|
0.76
|
|
89
|
Macrophage inhibitor, semapimod, reduces tumor necrosis factor-alpha in myocardium in a rat model of ischemic heart failure.
|
J Cardiovasc Pharmacol
|
2004
|
0.76
|
|
90
|
Is myocardial recovery possible and how do you measure it?
|
Curr Cardiol Rep
|
2012
|
0.76
|
|
91
|
Cardiac contractility modulation: a new technologically advanced placebo?
|
Heart Rhythm
|
2006
|
0.75
|
|
92
|
Physiological characterization of the SynCardia total artificial heart in a mock circulation system.
|
ASAIO J
|
2015
|
0.75
|
|
93
|
Partial mechanical circulatory support in an ovine model of post-infarction remodeling.
|
J Heart Lung Transplant
|
2013
|
0.75
|
|
94
|
Reply: Is Pump the Answer to Heart Failure With Preserved Ejection Fraction?
|
JACC Heart Fail
|
2016
|
0.75
|
|
95
|
Quantification of the impaired cardiac output response to exercise in heart failure: application of a non-invasive device.
|
J Sports Sci Med
|
2009
|
0.75
|
|
96
|
Intramyocardial left ventricle-to-coronary artery stent: a novel approach for the treatment of coronary artery disease.
|
Ann Thorac Surg
|
2005
|
0.75
|
|
97
|
Extracorporeal Membrane Oxygenation for End-Stage Interstitial Lung Disease With Secondary Pulmonary Hypertension at Rest and Exercise: Insights From Simulation Modeling.
|
ASAIO J
|
2017
|
0.75
|
|
98
|
Direct cardiac compression devices.
|
J Heart Lung Transplant
|
2002
|
0.75
|
|
99
|
Accuracy of the HVAD Pump Flow Estimation Algorithm.
|
ASAIO J
|
2015
|
0.75
|
|
100
|
Transmyocardial laser revascularization: a review of basic and clinical aspects.
|
Am J Cardiovasc Drugs
|
2002
|
0.75
|
|
101
|
Direct left ventricle-to-coronary artery stent restores perfusion to chronic ischemic swine myocardium.
|
Heart Surg Forum
|
2006
|
0.75
|
|
102
|
Physiologic determinants of mitral inflow pattern using a computer simulation: insights into Doppler echocardiography in diverse phenotypes.
|
Echocardiography
|
2009
|
0.75
|
|
103
|
The use of a CircuLite micro-pump for congenitally corrected transposition of the great arteries.
|
Eur J Cardiothorac Surg
|
2012
|
0.75
|
|
104
|
Cardiac contractility modulation in patients with advanced heart failure.
|
Expert Rev Cardiovasc Ther
|
2013
|
0.75
|
|
105
|
Methodological Issues and Their Impact on Conclusions.
|
JACC Cardiovasc Interv
|
2017
|
0.75
|
|
106
|
Direct left ventricle to great cardiac vein retroperfusion: a novel alternative to myocardial revascularization.
|
Heart Surg Forum
|
2006
|
0.75
|
|
107
|
Magnetic resonance assessment of myocardial perfusion via catheter-based ventricle-coronary vein bypass in porcine myocardial infarction model.
|
Catheter Cardiovasc Interv
|
2006
|
0.75
|
|
108
|
Treating heart failure with cardiac contractility modulation electrical signals.
|
Curr Heart Fail Rep
|
2006
|
0.75
|
|
109
|
Association Between Antecedent Statin Use and Decreased Mortality in Hospitalized Patients with COVID-19.
|
Res Sq
|
2020
|
0.75
|
|
110
|
Local intra-renal fenoldopam infusion causes greater increases in renal artery flow velocity than systemic intravenous fenoldopam infusion: a pilot study.
|
EuroIntervention
|
2005
|
0.75
|
|
111
|
Repeated Ramp Tests on Stable LVAD Patients Reveal Patient-Specific Hemodynamic Fingerprint.
|
ASAIO J
|
2017
|
0.75
|
|
112
|
Catheter-based ventricle-coronary vein bypass.
|
Catheter Cardiovasc Interv
|
2005
|
0.75
|
|
113
|
Innovative devices for advanced heart failure: exploring the current state and future direction of device therapies.
|
Curr Opin Cardiol
|
2015
|
0.75
|
|
114
|
The evolving role of coronary angiography and fluoroscopy in cardiac diagnosis and intervention.
|
EuroIntervention
|
2007
|
0.75
|
|
115
|
Modeling left atrial volume, shape, and contraction patterns in normal subjects by cardiac magnetic resonance imaging.
|
Int J Cardiol
|
2013
|
0.75
|
|
116
|
HVAD Flow Waveform Morphologies: Theoretical Foundation and Implications for Clinical Practice.
|
ASAIO J
|
2017
|
0.75
|
|
117
|
Alternatives to traditional coronary bypass surgery.
|
Semin Thorac Cardiovasc Surg
|
2002
|
0.75
|
|
118
|
HVAD Waveform Analysis as a Noninvasive Marker of Pulmonary Capillary Wedge Pressure: A First Step Toward the Development of a Smart Left Ventricular Assist Device Pump.
|
ASAIO J
|
2017
|
0.75
|